Tags : Injectio

Henlius HLX02 (Trastuzumab for Injection) Receives EU GMP Certificates

Shots: Henlius has received two EU GMP certificate for drug substance (DS) line and drug product (DP) line for HLX02 (trastuzumab biosimilar) and has become the first EU certified site to self-develop an Ab drug depicting the company has commercial-scale manufacturing facility and quality management as per EU standards The EU GMP inspection is recognized […]Read More